Global IVD Market Research Report 2024
Published on: 2024-01-04 | No of Pages : 400 | Industry : Medical
Publisher : MRA | Format : PDF
Global IVD Market Research Report 2024
In vitro diagnostics are tests done on samples such as blood or tissue that have been taken from the human body. In vitro diagnostics can detect diseases or other conditions, and can be used to monitor a person’s overall health to help cure, treat, or prevent diseases.
According to MRAResearch’s new survey, global IVD market is projected to reach US$ 8693.1 million in 2033, increasing from US$ 7012 million in 2022, with the CAGR of 2.7% during the period of 2023 to 2033. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole IVD market research.
In vitro diagnostics may also be used in precision medicine to identify patients who are likely to benefit from specific treatments or therapies. These in vitro diagnostics can include next generation sequencing tests, which scan a person’s DNA to detect genomic variations. Some tests are used in laboratory or other health professional settings and other tests are for consumers to use at home.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global IVD market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Roche Diagnostics
Danaher Corporation
Abbott Laboratories
Siemens
Sysmex
Thermo Fisher Scientific
Becton, Dickinson and Company
Biomérieux Sa
Bio-Rad Laboratories
Johnson & Johnson
Agilent Technologies
Qiagen
Diasorin
Ortho Clinical Diagnostics
Segment by Type
Immuno Diagnostics
Chemistry Diagnostics
Molecular Diagnostics
POCT
Others
Diabetes
Infectious Diseases
Oncology/Cancer
Cardiology
Nephrology
Autoimmune Diseases
Drug Testing/Pharmacogenomics
HIV/AIDS
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The IVD report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Global market size, regional market size. Market Opportunities and Challenges
Chapter 3Companies’ Competition Patterns
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6 to 10Country Level Value Analysis
Chapter 11Companies' Outline
Chapter 12Market Conclusions
Chapter 13Research Methodology and Data Source
According to MRAResearch’s new survey, global IVD market is projected to reach US$ 8693.1 million in 2033, increasing from US$ 7012 million in 2022, with the CAGR of 2.7% during the period of 2023 to 2033. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole IVD market research.
In vitro diagnostics may also be used in precision medicine to identify patients who are likely to benefit from specific treatments or therapies. These in vitro diagnostics can include next generation sequencing tests, which scan a person’s DNA to detect genomic variations. Some tests are used in laboratory or other health professional settings and other tests are for consumers to use at home.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global IVD market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Roche Diagnostics
Danaher Corporation
Abbott Laboratories
Siemens
Sysmex
Thermo Fisher Scientific
Becton, Dickinson and Company
Biomérieux Sa
Bio-Rad Laboratories
Johnson & Johnson
Agilent Technologies
Qiagen
Diasorin
Ortho Clinical Diagnostics
Segment by Type
Immuno Diagnostics
Chemistry Diagnostics
Molecular Diagnostics
POCT
Others
Segment by Application
Diabetes
Infectious Diseases
Oncology/Cancer
Cardiology
Nephrology
Autoimmune Diseases
Drug Testing/Pharmacogenomics
HIV/AIDS
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The IVD report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Global market size, regional market size. Market Opportunities and Challenges
Chapter 3Companies’ Competition Patterns
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6 to 10Country Level Value Analysis
Chapter 11Companies' Outline
Chapter 12Market Conclusions
Chapter 13Research Methodology and Data Source